• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>GMO Quality III

GMO Quality III

  1. All
  2. Morningstar Articles
  3. Investing
  4. Research
  1. Which Funds Top Readers' Wishlists?

    Small- and mid-cap holdings top readers' lists of attractive funds that are closed or otherwise unavailable.

  2. Fund Moat Ratings and the Bear Market

    Wide-moat funds were the stars of the recent downturn.

  3. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

  4. Chuck Joyce Steps Down From GMO Quality

    Joyce is also set to leave GMO. Also, American Century's LIVESTRONG funds withstand Lance Armstrong controversy, Dreyfus' CEO departs, manager changes at Fidelity and American Century, and analyst reductions at UBS Global Asset Management.

  5. Taking the Road Less Traveled to Safety

    In the rush to index, high active share could, paradoxically, be a way to cut volatility.

  6. Might Makes Right

    The market has rarely discounted large, strong companies this cheaply, argue Steven Romick of FPA and Ben Inker of GMO.

  7. Big Funds that Avoided Troubled Financials

    Which mutual funds have managed to sidestep the carnage?

Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.